Literature DB >> 16840711

Gene expression profiling in schizophrenia and related mental disorders.

Kazuya Iwamoto1, Tadafumi Kato.   

Abstract

The etiology and pathophysiology of schizophrenia and related mental disorders such as bipolar disorder and major depression remain largely unclear. Recent advances in mRNA profiling techniques made it possible to perform genome-wide gene expression analysis in a hypothesis-free manner. It was thought that this large-scale data mining approach would reveal unknown molecular cascades involved in mental disorders. Contrary to this initial expectation, however, DNA microarray results in psychiatric fields have been notoriously discordant. Here the authors review the findings of DNA microarray analysis, focusing on systematic gene expression changes in schizophrenia, as well as alterations in the expression of specific genes, that have been reported and replicated. The authors also address the probable causes for the discordance among studies, possible ways to solve the problem, and their preferred approach for data interpretation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16840711     DOI: 10.1177/1073858406287536

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  29 in total

1.  Genome scanning by composite likelihood.

Authors:  Newton Morton; Nikolas Maniatis; Weihua Zhang; Sarah Ennis; Andrew Collins
Journal:  Am J Hum Genet       Date:  2006-12-05       Impact factor: 11.025

Review 2.  Gene expression in the etiology of schizophrenia.

Authors:  Nicholas J Bray
Journal:  Schizophr Bull       Date:  2008-03-11       Impact factor: 9.306

3.  Decreased gene expression activity as a result of a mutation in the calreticulin gene promoter in a family case of schizoaffective disorder.

Authors:  S Farashi; M Ohadi; S Hosseinkhani; H Darvish; A Mirabzadeh
Journal:  Cogn Neurodyn       Date:  2015-11-27       Impact factor: 5.082

Review 4.  Use of peripheral blood transcriptome biomarkers for epilepsy prediction.

Authors:  Stanislav L Karsten; Lili C Kudo; Anatol J Bragin
Journal:  Neurosci Lett       Date:  2011-03-17       Impact factor: 3.046

Review 5.  Quantitative analysis of 5HT(2C) receptor RNA editing patterns in psychiatric disorders.

Authors:  Richard T O'Neil; Ronald B Emeson
Journal:  Neurobiol Dis       Date:  2011-09-03       Impact factor: 5.996

Review 6.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

7.  Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia.

Authors:  Dominique Arion; Travis Unger; David A Lewis; Pat Levitt; Károly Mirnics
Journal:  Biol Psychiatry       Date:  2007-06-13       Impact factor: 13.382

Review 8.  miRNAs in NMDA receptor-dependent synaptic plasticity and psychiatric disorders.

Authors:  Hongmei Shen; Zheng Li
Journal:  Clin Sci (Lond)       Date:  2016-07-01       Impact factor: 6.124

9.  Molecular profiles of schizophrenia in the CNS at different stages of illness.

Authors:  Sujatha Narayan; Bin Tang; Steven R Head; Timothy J Gilmartin; J Gregor Sutcliffe; Brian Dean; Elizabeth A Thomas
Journal:  Brain Res       Date:  2008-08-16       Impact factor: 3.252

10.  Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects.

Authors:  Kwang H Choi; Brandon W Higgs; Serge Weis; Jonathan Song; Ida C Llenos; Jeannette R Dulay; Robert H Yolken; Maree J Webster
Journal:  BMC Psychiatry       Date:  2009-09-16       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.